Physician profile
Robert H Wilds
NPI 1891867909
$1,417.12
in general payments reported to CMS, 2019-2025
13 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $434 · 2020: $116 · 2021: $146 · 2022: $195 · 2023: $526.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $526.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $526.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $264.80 | 2019-2021 | |
| Horizon Therapeutics Plc | $239.61 | 2022-2023 | Tepezza |
| Allergan, INC. | $123.63 | 2019 | |
| Johnson & Johnson Surgical Vision, INC. | $116.86 | 2023 | Tecnis Iol |
| Genentech USA, INC. | $116.00 | 2020 | |
| Mallinckrodt Hospital Products INC. | $98.25 | 2023 | Acthar |
| Sun Pharmaceutical Industries INC. | $95.76 | 2023 | Cequa |
| Oyster Point Pharma, INC. | $90.39 | 2023 | Tyrvaya |
| Johnson & Johnson Vision Care, INC. | $80.18 | 2022 | |
| Avedro INC. | $77.13 | 2019 | |
| Shire North American Group INC | $50.00 | 2019 | |
| New World Medical,INC. | $44.88 | 2019 | |
| Lumenis, INC | $19.63 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Wilds listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.